These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28567595)

  • 1. Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?
    de Azevedo LA; Bonazzoni J; Wagner SC; Farias MG; Bittar CM; Daudt L; de Castro SM
    Mol Diagn Ther; 2017 Aug; 21(4):437-442. PubMed ID: 28567595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of UGT1A1 promoter polymorphism, α-thalassemia and β
    Batista JVGF; Arcanjo GS; Batista THC; Sobreira MJ; Santana RM; Domingos IF; Hatzlhofer BL; Falcão DA; Pereira-Martins DA; Oliveira JM; Araujo AS; Laranjeira LPM; Medeiros FS; Albuquerque FP; Albuquerque DM; Santos MN; Hazin MF; Dos Anjos AC; Costa FF; Araujo AS; Lucena-Araujo AR; Bezerra MA
    Ann Hematol; 2021 Apr; 100(4):903-911. PubMed ID: 33523291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia.
    Chaar V; Kéclard L; Etienne-Julan M; Diara JP; Elion J; Krishnamoorthy R; Romana M
    Am J Hematol; 2006 May; 81(5):377-9. PubMed ID: 16628735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
    Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
    Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
    AlFadhli S; Al-Jafer H; Hadi M; Al-Mutairi M; Nizam R
    PLoS One; 2013; 8(10):e77681. PubMed ID: 24204915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia.
    Chaar V; Kéclard L; Diara JP; Leturdu C; Elion J; Krishnamoorthy R; Clayton J; Romana M
    Haematologica; 2005 Feb; 90(2):188-99. PubMed ID: 15710570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UGT1A1 promoter polymorphism associated with serum bilirubin level in Saudi patients with sickle cell disease.
    Hamad Z; Aljedai A; Halwani R; AlSultan A
    Ann Saudi Med; 2013; 33(4):372-6. PubMed ID: 24060717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease.
    Vasavda N; Menzel S; Kondaveeti S; Maytham E; Awogbade M; Bannister S; Cunningham J; Eichholz A; Daniel Y; Okpala I; Fulford T; Thein SL
    Br J Haematol; 2007 Jul; 138(2):263-70. PubMed ID: 17593033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene.
    Chaouch L; Talbi E; Moumni I; Ben Chaabene A; Kalai M; Chaouachi D; Mallouli F; Ghanem A; Abbes S
    Dis Markers; 2013; 35(2):67-72. PubMed ID: 24167350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
    Sheehan VA; Luo Z; Flanagan JM; Howard TA; Thompson BW; Wang WC; Kutlar A; Ware RE;
    Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia.
    Passon RG; Howard TA; Zimmerman SA; Schultz WH; Ware RE
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):448-51. PubMed ID: 11878580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism.
    Martins R; Morais A; Dias A; Soares I; Rolão C; Ducla-Soares JL; Braga L; Seixas T; Nunes B; Olim G; Romão L; Lavinha J; Faustino P
    J Hum Genet; 2008; 53(6):524-528. PubMed ID: 18392554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.
    Olatunya OS; Albuquerque DM; Akanbi GO; Aduayi OS; Taiwo AB; Faboya OA; Kayode TS; Leonardo DP; Adekile A; Costa FF
    BMC Med Genet; 2019 Oct; 20(1):160. PubMed ID: 31619193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism.
    Mobaraki S; Nissen PH; Donskov F; Wozniak A; Van Herck Y; Coosemans L; van Nieuwenhuyse T; Lambrechts D; Bechter O; Baldewijns M; Roussel E; Laenen A; Beuselinck B
    Clin Genitourin Cancer; 2024 Oct; 22(5):102180. PubMed ID: 39155162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.
    Patel DK; Purohit P; Dehury S; Das P; Dutta A; Meher S; Patel S; Bag S; Mashon RS; Das K
    Int J Lab Hematol; 2014 Aug; 36(4):444-50. PubMed ID: 24245819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.
    Milton JN; Sebastiani P; Solovieff N; Hartley SW; Bhatnagar P; Arking DE; Dworkis DA; Casella JF; Barron-Casella E; Bean CJ; Hooper WC; DeBaun MR; Garrett ME; Soldano K; Telen MJ; Ashley-Koch A; Gladwin MT; Baldwin CT; Steinberg MH; Klings ES
    PLoS One; 2012; 7(4):e34741. PubMed ID: 22558097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.
    Carpenter SL; Lieff S; Howard TA; Eggleston B; Ware RE
    Am J Hematol; 2008 Oct; 83(10):800-3. PubMed ID: 18756540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UGT1A1 (TA)
    Joly P; Renoux C; Lacan P; Bertrand Y; Cannas G; Garnier N; Cuzzubbo D; Kebaïli K; Renard C; Gauthier A; Pialoux V; Martin C; Romana M; Connes P
    Eur J Haematol; 2017 Mar; 98(3):296-301. PubMed ID: 27981643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between promoter and coding region mutations of UDP-glucuronosyltransferase 1A1 and beta-thalassemia/Hb E with cholelithiasis.
    Tankanitlert J; Morales NP; Fucharoen P; Fucharoen S; Chantharaksri U
    Eur J Haematol; 2008 Apr; 80(4):351-5. PubMed ID: 18081723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilirubin concentrations in thalassemia heterozygotes in university students.
    Huang YY; Huang MJ; Wang HL; Chan CC; Huang CS
    Eur J Haematol; 2011 Apr; 86(4):317-23. PubMed ID: 21255081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.